Prioritisation of non-coding somatic mutations in cancer
|Title:||Prioritisation of non-coding somatic mutations in cancer||Authors:||Piraino, Scott William||metadata.dc.contributor.advisor:||Furney, Simon J||Permanent link:||http://hdl.handle.net/10197/8697||Date:||2017||Abstract:||The identification of somatic mutations that play a causal role in tumour development, so called “driver” mutations, is of critical importance for understanding how cancers form and how they might be treated. Several large whole exome sequencing projects have identified genes that are recurrently mutated in cancer patients, indicating a possible causal role in tumourogenesis. While the landscape of coding drivers has been extensively studied and many of the most prominent driver genes are well characterised, comparatively less is known about what driver mutations may reside in the non-coding regions of the genome. Using mutations identified in over 1300 whole cancer genomes, I have identified regions, both coding and non-coding, that are recurrent targets of somatic mutations in cancer. Using both recurrence and information on evolutionary conservation to score regions of the genome as potential driver mutations, I have identified putative driver regions that include both well known drivers as well as novel recurrently mutated regions.||Type of material:||Master Thesis||Publisher:||University College Dublin. School of Medicine||Advisor:||M.Sc.||Copyright (published version):||2017 the author||Keywords:||Cancer genome sequencing;Mutational hotspots;Non-coding mutations||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Medicine Theses|
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.